Β‐2 Agonists as Misusing Drugs? Assessment of both Clenbuterol‐ and Salbutamol‐related European Medicines Agency Pharmacovigilance Database Reports. Issue 2 (6th April 2018)
- Record Type:
- Journal Article
- Title:
- Β‐2 Agonists as Misusing Drugs? Assessment of both Clenbuterol‐ and Salbutamol‐related European Medicines Agency Pharmacovigilance Database Reports. Issue 2 (6th April 2018)
- Main Title:
- Β‐2 Agonists as Misusing Drugs? Assessment of both Clenbuterol‐ and Salbutamol‐related European Medicines Agency Pharmacovigilance Database Reports
- Authors:
- Milano, Giulia
Chiappini, Stefania
Mattioli, Francesca
Martelli, Antonietta
Schifano, Fabrizio - Abstract:
- Abstract: A recent years' increase in misusing levels of image‐ and performance‐ enhancing drugs (IPEDs) has been observed. Out of these drugs, beta‐2 agonists have recently emerged for their potential of misuse, especially for slimming and bodybuilding purposes. To this perspective, clenbuterol ('the size zero pill') has been reported as being both popular and widely available from the illegal market. All clenbuterol and salbutamol misuse/abuse/dependence/withdrawal/overdose/off‐label spontaneous reports (2006–2016) from the European Medicines Agency (EMA) EudraVigilance (EV) database were collected and analysed by age range, gender, concomitant therapies and source of information. From the EV database, 55 of a total number of 920 'suspect' misuse/abuse/dependence/withdrawal/overdose/off‐label ADRs (e.g. 5.97%; corresponding to 25 of 138 individuals) and 1310 of 62, 879 ADRs (e.g. 2.08%; corresponding to 474 of 6923 individuals) were, respectively, associated with clenbuterol (typically ingested in combination with a range of anabolic steroids) and salbutamol. Proportional reporting ratio (PRR) value for misuse/abuse ADRs was higher (PRR = 18.38) for clenbuterol in comparison with salbutamol. Clenbuterol misuse/abuse could be a cause for major concern, especially in vulnerable individuals.
- Is Part Of:
- Basic & clinical pharmacology & toxicology. Volume 123:Issue 2(2018)
- Journal:
- Basic & clinical pharmacology & toxicology
- Issue:
- Volume 123:Issue 2(2018)
- Issue Display:
- Volume 123, Issue 2 (2018)
- Year:
- 2018
- Volume:
- 123
- Issue:
- 2
- Issue Sort Value:
- 2018-0123-0002-0000
- Page Start:
- 182
- Page End:
- 187
- Publication Date:
- 2018-04-06
- Subjects:
- Pharmacology -- Periodicals
Toxicology -- Periodicals
Pharmacology -- Periodicals
Toxicology -- Periodicals
Pharmacology, Clinical -- Periodicals
Computer network resources
Electronic journals
615.1 - Journal URLs:
- http://firstsearch.oclc.org/journal=1742-7835;screen=info;ECOIP ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1742-7843 ↗
http://www.blackwell-synergy.com/servlet/useragent?func=showIssues&code=pto ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/bcpt.12991 ↗
- Languages:
- English
- ISSNs:
- 1742-7835
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 1863.914250
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 6900.xml